Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry

Enrolling by invitation

Conditions studied: Coronary Artery Disease

In brief

The overall objective of CONFIRM2 is to perform the largest cardiovascular phenotype outcomes study ever.

Key facts

Study ID

NCT04279496

Run by

Cleerly, Inc.

People needed

15000

Starts

2020-06-01

Expected to finish

2027-06-01

Last updated by the study team

2026-06-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age >18 years
• Undergoing clinically indicated CCTA with >64-detector row CT
• Signed informed consent, including of release of medical information, long term follow-up and Health Insurance Portability and Accountability Act (HIPAA) documentation

You may not qualify if…

• Individuals unable to provide informed consent
• Non-cardiac illness with life expectancy < 2 years
• Pregnancy

Where it is running

• University of Virginia — Charlottesville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.